These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1830908)

  • 1. A study of the clinical significance of lipoprotein (a) in nephrotic syndrome.
    Takegoshi T; Kitoh C; Haba T; Hirai J; Wakasugi T; Saga T; Yamazaki Y; Mabuchi H
    Jpn J Med; 1991; 30(1):21-5. PubMed ID: 1830908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) levels in the nephrotic syndrome.
    Kanno H; Saito E; Fujioka T; Yasugi T
    Intern Med; 1992 Aug; 31(8):1004-8. PubMed ID: 1477459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
    Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum lipoprotein abnormalities in patients with nephrotic syndrome and effects of steroid therapy].
    Kohtoku N; Okuda F; Shimizu K; Takagi H; Fujii Z; Fujii H; Kusukawa R
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):335-44. PubMed ID: 2747006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated lipoprotein (a) levels in primary nephrotic syndrome.
    Faucher C; Doucet C; Baumelou A; Chapman J; Jacobs C; Thillet J
    Am J Kidney Dis; 1993 Dec; 22(6):808-13. PubMed ID: 8250027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J; Simó JM; Vilella E; Camps J; Espinel E; Villabona C
    Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipoprotein(a)aemia in nephrotic syndrome.
    Thiery J; Ivandic B; Bahlmann G; Walli AK; Seidel D
    Eur J Clin Invest; 1996 Apr; 26(4):316-21. PubMed ID: 8732490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
    Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
    Eur J Clin Invest; 1997 Feb; 27(2):169-77. PubMed ID: 9061312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
    Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse.
    Mahmud S; Jahan S; Hossain MM
    Mymensingh Med J; 2011 Jul; 20(3):402-6. PubMed ID: 21804502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD; Azrolan N; Thomas L; Roberts KG; Bostom A; Zhao ZH; Friedman EA
    Am J Kidney Dis; 1995 Jul; 26(1):170-7. PubMed ID: 7611249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) in nephrotic syndrome.
    Stenvinkel P; Berglund L; Heimbürger O; Pettersson E; Alvestrand A
    Kidney Int; 1993 Nov; 44(5):1116-23. PubMed ID: 8264144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A; Erasmus RT; Anjorin SA
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of hyperLp(a)aemia, associated with systemic lupus erythematosus, suffering from myocardial infarction and cerebral infarction.
    Takegoshi T; Haba T; Hirai J; Saga T; Kitoh C; Mabuchi H
    Jpn J Med; 1990; 29(1):77-84. PubMed ID: 2145457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin.
    Karádi I; Romics L; Pálos G; Domán J; Kaszás I; Hesz A; Kostner GM
    Clin Chem; 1989 Oct; 35(10):2121-3. PubMed ID: 2529062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
    Wanner C; Böhler J; Eckardt HG; Wieland H; Schollmeyer P
    Clin Nephrol; 1994 Mar; 41(3):138-43. PubMed ID: 8187355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND
    Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
    Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.